Literature DB >> 7371130

Perspectives on systolic hypertension. The Framingham study.

W B Kannel, T R Dawber, D L McGee.   

Abstract

Diastolic hypertension has been widely and justifiably accepted as a cause of cardiovascular mortality. However, it has also been accepted that the cardiovascular sequelae of hypertension derive chiefly from the diastolic component. Because systolic and diastolic pressure are usually highly correlated it is not easy to dissociate the effects of each. Statistical analysis suggests that systolic pressure is actually the more potent contributor to cardiovascular sequelae. Even isolated systolic pressure elevation is associated witn an excess cardiovascular mortality. At low diastolic pressures (i.e., less than 95 mm Hg), risk rises with the level of systolic pressure. Also, isolated systolic hypertension is most ominous in the elderly, in whom it is highly prevalent. Isolated systolic hypertension was related to the occurrence of "direct" complications as well as to atherosclerotic sequelae. It was also associated with excess mortality, taking into account rigid vessels as judged from pulse-wave recordings. Trials to determine whether the treatment of isolated systolic hypertension is efficacious for avoiding its demonstrated excess cardiovascular morbidity and mortality are urgently needed.

Entities:  

Mesh:

Year:  1980        PMID: 7371130     DOI: 10.1161/01.cir.61.6.1179

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  58 in total

1.  Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association.

Authors: 
Journal:  Heart       Date:  1998-12       Impact factor: 5.994

2.  Blood pressure levels and variance assessed by ambulatory monitoring: optimal parameters.

Authors:  F E Yates; L A Benton
Journal:  Ann Biomed Eng       Date:  1990       Impact factor: 3.934

Review 3.  What is the clinical relevance of isolated systolic hypertension?

Authors:  J P Emeriau
Journal:  Drugs Aging       Date:  1992 May-Jun       Impact factor: 3.923

4.  Low-dose pravastatin and age-related differences in risk factors for cardiovascular disease in hypercholesterolaemic Japanese: analysis of the management of elevated cholesterol in the primary prevention group of adult Japanese (MEGA study).

Authors:  Noriaki Nakaya; Kyoichi Mizuno; Yasuo Ohashi; Tamio Teramoto; Shinji Yokoyama; Katsumi Hirahara; Masahiro Mizutani; Haruo Nakamura
Journal:  Drugs Aging       Date:  2011-09-01       Impact factor: 3.923

5.  Screening recommendations for the elderly.

Authors:  M H Beers; A Fink; J C Beck
Journal:  Am J Public Health       Date:  1991-09       Impact factor: 9.308

Review 6.  Risk factors in stroke.

Authors:  P Mustacchi
Journal:  West J Med       Date:  1985-08

7.  Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41.

Authors:  Niranjana Natarajan; Daijiro Hori; Sheila Flavahan; Jochen Steppan; Nicholas A Flavahan; Dan E Berkowitz; Jennifer L Pluznick
Journal:  Physiol Genomics       Date:  2016-09-23       Impact factor: 3.107

Review 8.  Prevalence and implications of uncontrolled systolic hypertension.

Authors:  William B Kannel
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 9.  Treatment of hypertension based on both systolic and diastolic pressure could influence the cost of therapy.

Authors:  M Safar
Journal:  Cardiovasc Drugs Ther       Date:  1989-12       Impact factor: 3.727

10.  Blood pressure in infants children and adolescents.

Authors:  A J Moss
Journal:  West J Med       Date:  1981-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.